Agonist induced conformational changes in the NMDA receptor

激动剂诱导 NMDA 受体构象变化

基本信息

项目摘要

Abstract: NMDA receptors are ligand-gated ion channels that play a critical role in the function of the central nervous system and are involved in processes such as synaptic plasticity, learning, and memory. In addition to their physiological functions, NMDARs are also implicated in a number of neurological diseases and conditions, including ischemic stroke and epilepsy. The diverse roles that NMDA receptors fill make it critical that the function and regulation of these receptors are fully understood. The recent structures have provided insight into the architecture and end state structures of NMDA receptors providing a rich foundation for structure- dynamic investigation of the receptor which will allow for detailed investigations of all the conformational states that the protein explores. This is required as there are still several unanswered questions such as mechanism underlying partial agonism as well as mechanism of allosteric communication between the glutamate and glycine binding. Single molecule Förster Resonance Energy Transfer (smFRET) method is ideally suited for such investigations as it allows for the characterization of all the states that the proteins probes and dynamics of transitions between the states, which then can be correlated to the extensive functional information available for the receptor. The research proposed herein seeks to fill these important gaps in knowledge through two aims: to Determine the mechanism of partial agonism in the NMDA receptor and to Study the allosteric communication between the glutamate- and glycine-binding subunits of the NMDA receptor. The research proposed will provide a significant step forward in the understanding of the function and regulation of the NMDA receptor. This research pursuit, therefore, is in keeping with the stated mission of the NIGMS to support “basic research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment and prevention”.
摘要: NMDA受体是配体门控离子通道,在中枢神经功能中发挥关键作用 神经系统,并参与突触可塑性,学习和记忆等过程。除了它们 除了生理功能外,NMDAR还涉及许多神经疾病和病症, 包括缺血性中风和癫痫NMDA受体所起的不同作用使其在治疗中发挥重要作用。 这些受体的功能和调节是完全清楚的。最近的结构提供了深入了解 NMDA受体的结构和终态结构为结构动力学提供了丰富的基础 研究受体,这将允许详细研究所有的构象状态, 蛋白质探索这是必要的,因为仍然有几个未回答的问题,如机制 潜在的部分激动作用以及谷氨酸和 甘氨酸结合单分子Förster共振能量转移(smFRET)方法非常适合于 这样的调查,因为它允许表征的所有国家的蛋白质探针和动力学 状态之间的转换,然后可以将其与可用的广泛功能信息相关联 for the receptor受体.本文提出的研究旨在通过两个方面填补这些重要的知识空白 目的:探讨NMDA受体部分激动的机制,研究NMDA受体的变构作用, 在NMDA受体的谷氨酸和甘氨酸结合亚基之间的通信。研究 建议将提供一个重要的一步,在理解的功能和监管的 NMDA受体。因此,这项研究工作符合国家地理研究所的既定使命, “基础研究增加了对生物过程的理解,并为以下方面的进步奠定了基础: 疾病诊断、治疗和预防”。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ryan James Durham其他文献

Ryan James Durham的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ryan James Durham', 18)}}的其他基金

Agonist induced conformational changes in the NMDA receptor
激动剂诱导 NMDA 受体构象变化
  • 批准号:
    9769506
  • 财政年份:
    2018
  • 资助金额:
    $ 3.25万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 3.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 3.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 3.25万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 3.25万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 3.25万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 3.25万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 3.25万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 3.25万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 3.25万
  • 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
  • 批准号:
    10534864
  • 财政年份:
    2023
  • 资助金额:
    $ 3.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了